Yüklüyor......
MicroRNA‐483 amelioration of experimental pulmonary hypertension
Endothelial dysfunction is critically involved in the pathogenesis of pulmonary arterial hypertension (PAH) and that exogenously administered microRNA may be of therapeutic benefit. Lower levels of miR‐483 were found in serum from patients with idiopathic pulmonary arterial hypertension (IPAH), part...
Kaydedildi:
| Yayımlandı: | EMBO Mol Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7207157/ https://ncbi.nlm.nih.gov/pubmed/32324970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201911303 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|